Painreform Ltd (PRFX) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $3.20
• Market Cap: $1.87M
• P/E Ratio: 0.03
• EPS: $29.90
• 52-Week High: $16.45
• 52-Week Low: $2.57

Market Sentiment

Painreform Ltd currently has a Bearish sentiment score of -0.18.

About Painreform Ltd

PainReform Ltd. is a pioneering pharmaceutical company headquartered in Tel Aviv, Israel, specializing in the development of advanced therapies aimed at extending post-surgical pain relief. Through its proprietary drug delivery technology, the company addresses critical pain management challenges, enhancing the effectiveness and safety of analgesics. With a strong focus on transforming patient care in the postoperative environment, PainReform is well-positioned to lead innovations in the evol...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Painreform Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PRFX pay dividends?

Painreform Ltd (PRFX) does not currently pay a regular dividend.

What is PRFX's P/E ratio?

Painreform Ltd has a price-to-earnings (P/E) ratio of 0.03.

What is PRFX's market cap?

Painreform Ltd (PRFX) has a market capitalization of $1.87M with a current stock price of $3.20.